434 related articles for article (PubMed ID: 27861439)
1. Trends in Tramadol: Pharmacology, Metabolism, and Misuse.
Miotto K; Cho AK; Khalil MA; Blanco K; Sasaki JD; Rawson R
Anesth Analg; 2017 Jan; 124(1):44-51. PubMed ID: 27861439
[TBL] [Abstract][Full Text] [Related]
2. Clinical pharmacology of tramadol.
Grond S; Sablotzki A
Clin Pharmacokinet; 2004; 43(13):879-923. PubMed ID: 15509185
[TBL] [Abstract][Full Text] [Related]
3. Effects of terbinafine and itraconazole on the pharmacokinetics of orally administered tramadol.
Saarikoski T; Saari TI; Hagelberg NM; Backman JT; Neuvonen PJ; Scheinin M; Olkkola KT; Laine K
Eur J Clin Pharmacol; 2015 Mar; 71(3):321-7. PubMed ID: 25560051
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacokinetics of tramadol in children].
Saudan S; Habre W
Ann Fr Anesth Reanim; 2007 Jun; 26(6):560-3. PubMed ID: 17524604
[TBL] [Abstract][Full Text] [Related]
5. Rifampicin markedly decreases the exposure to oral and intravenous tramadol.
Saarikoski T; Saari TI; Hagelberg NM; Neuvonen M; Neuvonen PJ; Scheinin M; Olkkola KT; Laine K
Eur J Clin Pharmacol; 2013 Jun; 69(6):1293-301. PubMed ID: 23242004
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of CYP2D6-mediated tramadol O-demethylation in methadone but not buprenorphine maintenance patients.
Coller JK; Michalakas JR; James HM; Farquharson AL; Colvill J; White JM; Somogyi AA
Br J Clin Pharmacol; 2012 Nov; 74(5):835-41. PubMed ID: 22369095
[TBL] [Abstract][Full Text] [Related]
7. Differential Consequences of Tramadol in Overdosing: Dilemma of a Polymorphic Cytochrome P450 2D6-Mediated Substrate.
Srinivas NR
J Pain Palliat Care Pharmacother; 2015 Sep; 29(3):272-5. PubMed ID: 26367475
[TBL] [Abstract][Full Text] [Related]
8. Impact of CYP genotype and inflammatory markers on the plasma concentrations of tramadol and its demethylated metabolites and drug tolerability in cancer patients.
Tanaka H; Naito T; Sato H; Hiraide T; Yamada Y; Kawakami J
Eur J Clin Pharmacol; 2018 Nov; 74(11):1461-1469. PubMed ID: 30051214
[TBL] [Abstract][Full Text] [Related]
9. [Pharmacology of tramadol].
Dayer P; Desmeules J; Collart L
Drugs; 1997; 53 Suppl 2():18-24. PubMed ID: 9190321
[TBL] [Abstract][Full Text] [Related]
10. Desmetramadol Has the Safety and Analgesic Profile of Tramadol Without Its Metabolic Liabilities: Consecutive Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Trials.
Zebala JA; Searle SL; Webster LR; Johnson MS; Schuler AD; Maeda DY; Kahn SJ
J Pain; 2019 Oct; 20(10):1218-1235. PubMed ID: 31005596
[TBL] [Abstract][Full Text] [Related]
11. Discovery and development of tramadol for the treatment of pain.
Bravo L; Mico JA; Berrocoso E
Expert Opin Drug Discov; 2017 Dec; 12(12):1281-1291. PubMed ID: 28920461
[TBL] [Abstract][Full Text] [Related]
12. Paroxetine, a cytochrome P450 2D6 inhibitor, diminishes the stereoselective O-demethylation and reduces the hypoalgesic effect of tramadol.
Laugesen S; Enggaard TP; Pedersen RS; Sindrup SH; Brøsen K
Clin Pharmacol Ther; 2005 Apr; 77(4):312-23. PubMed ID: 15903129
[TBL] [Abstract][Full Text] [Related]
13. ADME and toxicity considerations for tramadol: from basic research to clinical implications.
Doostmohammadi M; Rahimi HR
Expert Opin Drug Metab Toxicol; 2020 Jul; 16(7):627-640. PubMed ID: 32476523
[TBL] [Abstract][Full Text] [Related]
14. An overview of tramadol and its usage in pain management and future perspective.
Subedi M; Bajaj S; Kumar MS; Yc M
Biomed Pharmacother; 2019 Mar; 111():443-451. PubMed ID: 30594783
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the Ecstasy influence on tramadol and its main metabolite plasma concentration in rats.
Jamali B; Sheikholeslami B; Hosseinzadeh Ardakani Y; Lavasani H; Rouini MR
Drug Metab Pers Ther; 2017 Sep; 32(3):137-145. PubMed ID: 28917081
[TBL] [Abstract][Full Text] [Related]
16. Enantioselective pharmacokinetics of tramadol and its three main metabolites; impact of
Haage P; Kronstrand R; Josefsson M; Calistri S; van Schaik RHN; Green H; Kugelberg FC
Pharmacol Res Perspect; 2018 Jul; 6(4):e00419. PubMed ID: 29992026
[TBL] [Abstract][Full Text] [Related]
17. The Pharmacogenetics of Tramadol.
Lassen D; Damkier P; Brøsen K
Clin Pharmacokinet; 2015 Aug; 54(8):825-36. PubMed ID: 25910878
[TBL] [Abstract][Full Text] [Related]
18. [An atypical opioid analgesic: tramadol].
Keskinbora K; Aydinli I
Agri; 2006 Jan; 18(1):5-19. PubMed ID: 16783663
[TBL] [Abstract][Full Text] [Related]
19. IV tramadol: A novel option for US patients with acute pain-A review of its pharmacokinetics, abuse potential and clinical safety record.
Lu L; Harnett M; Reines SA
J Opioid Manag; 2020; 16(4):297-306. PubMed ID: 32885838
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
